Showing results (71-80 of 226) with videos related to
Sort By:
Pageof 23
Advances in Wound Care|February 15, 2014
Focal Adhesion Kinase: A Key Mediator of Transforming Growth Factor Beta Signaling in FibroblastsAndrew LeaskCellular Signalling|February 26, 2008
Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in sclerodermaAndrew LeaskArthritis Research & Therapy|June 16, 2006
Scar wars: is TGFbeta the phantom menace in scleroderma?Andrew LeaskCardiovascular Research|August 22, 2006
TGFbeta, cardiac fibroblasts, and the fibrotic responseAndrew LeaskExpert Opinion on Therapeutic Targets|July 16, 2013
CCN2: a novel, specific and valid target for anti-fibrotic drug interventionAndrew LeaskExpert Opinion on Emerging Drugs|April 27, 2012
Emerging targets for the treatment of sclerodermaAndrew LeaskAmerican Journal of Physiology. Cell Physiology|March 5, 2020
Conjunction junction, what's the function? CCN proteins as targets in fibrosis and cancersAndrew LeaskJournal of Cell Communication and Signaling|March 7, 2009
Trial by CCN2: a standardized test for fibroproliferative disease?Andrew LeaskJournal of Cell Communication and Signaling|April 22, 2009
What's in an intron? CCN1 mRNA splicing in cancerAndrew LeaskJournal of Cell Communication and Signaling|December 8, 2019
Breathe, breathe in the air: the anti-CCN2 antibody pamrevlumab (FG-3019) completes a successful phase II clinical trial for idiopathic pulmonary fibrosisAndrew LeaskPageof 23